HeartBeat.bio is a recently founded drug discovery company focusing on the development of a high-throughput 3D screening platform tackling cardiomyopathies, cardiotoxicity and heart failure. Our core technology is based on the worldwide first, self-organizing cardiac organoids (cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large-scale in vitro analysis of crucial clinical parameters associated with various cardiac diseases. The cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.

Management team

funding partners

red-stars.com data AG is an operative holding company engaged in the global penetration of highly scalable innovative technologies, utilizing and commercializing scientific IP and software.

Cooperation partners